Profil
Rainer Sturm worked as a Principal at Bertelsmann SE & Co. KGaA, Vice President-Finance at The Global Life Science Ventures GmbH, and Chief Financial Officer & Senior Vice President at numares AG from 2013 to 2018.
Anciens postes connus de Rainer Sturm
| Sociétés | Poste | Fin |
|---|---|---|
numares AG
numares AG Medical SpecialtiesHealth Technology Develops and markets medical tests for diagnostics and therapy monitoring | Directeur Financier/CFO | 01/09/2018 |
The Global Life Science Ventures GmbH
The Global Life Science Ventures GmbH Investment ManagersFinance GLSV is an active, long-term manager which aims to create and build value exclusively in life science companies in the UK, Switzerland, German-speaking countries and the US. They invest in many areas of the life sciences including the cancer, immunology, vaccines, biopharmaceuticals, indication-specific genomics, genomics tools, diagnostics, medical devices, healthcare services and cardiovascular areas. The firm primarily invests in early-stage companies that operate in significant markets with considerable upside potential, as well as in later-stage companies, including buyouts, which meet their investment in their home markets, GLSV is the lead investor or an active co-investor, while outside of their home markets they only act as a knowledgeable co-investor. | Directeur Financier/CFO | - |
| BERTELSMANN SE & CO. KGAA | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Bertelsmann SE & Co. KGaA
Bertelsmann SE & Co. KGaA Movies/EntertainmentConsumer Services Provides entertainment, radio broadcasting, book publishing, music and education services | Consumer Services |
The Global Life Science Ventures GmbH
The Global Life Science Ventures GmbH Investment ManagersFinance GLSV is an active, long-term manager which aims to create and build value exclusively in life science companies in the UK, Switzerland, German-speaking countries and the US. They invest in many areas of the life sciences including the cancer, immunology, vaccines, biopharmaceuticals, indication-specific genomics, genomics tools, diagnostics, medical devices, healthcare services and cardiovascular areas. The firm primarily invests in early-stage companies that operate in significant markets with considerable upside potential, as well as in later-stage companies, including buyouts, which meet their investment in their home markets, GLSV is the lead investor or an active co-investor, while outside of their home markets they only act as a knowledgeable co-investor. | Finance |
numares AG
numares AG Medical SpecialtiesHealth Technology Develops and markets medical tests for diagnostics and therapy monitoring | Health Technology |
















